Senti Biosciences Holdings, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · South San Francisco, CA
SNTI chart
What traders are saying about $SNTI
Latest postsSenti Biosciences Holdings, Inc. news
- Senti Biosciences announces board resignation and sets CVR record date
Investing.com ·
- Senti Biosciences director Edward Mathers resigns
TradingView ·
- Form 8K Senti Biosciences Holdings Inc For: 27 October By Investing.com
Investing.com UK ·
- Form 8-K Senti Biosciences Holdin For: Oct 26
StreetInsider ·
- BC-Most Active Stocks
Yahoo Finance ·
- 12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga ·
- Form 8K Senti Biosciences Holdings Inc For: 26 October By Investing.com
Investing.com Nigeria ·
- Senti Biosciences Merger Adds Up to $60 Million in Product Milestone Payments
TradingView ·
- Form 4 Senti Biosciences Holdings Inc: Kanya Rajangam (Pres. & Chief Med. & Dev. Off.) For: 21 October
Investing.com Canada ·
- Form 4 Senti Biosciences Holdings Inc: Timothy K. Lu (Director, CEO) For: 21 October
Investing.com Nigeria ·
- Senti Biosciences (SNTI) Stock Price, News & Analysis $SNTI
MarketBeat ·
- Senti Biosciences Holdings, Inc. Estimates – NASDAQ:SNTI
TradingView ·
Senti Biosciences Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $22,000 | $0 | $2.0M | $3.3M |
| Net income | -$61.4M | -$52.8M | -$71.1M | -$58.2M |
| Diluted EPS | $-2.73 | $-12.03 | $-16.01 | $-2.23 |
| Total assets (year end) | $51.2M | $97.8M | $119.5M | $180.8M |
| Cash and equivalents (year end) | $16.4M | $48.3M | $35.9M | $57.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Senti Biosciences Holdings, Inc.
- Ticker
- SNTI (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1854270
- Former names
- Senti Biosciences, Inc., Senti Biosciences, Inc.\, Dynamics Special Purpose Corp.
Frequently asked questions
What exchange is Senti Biosciences Holdings, Inc. listed on?
Senti Biosciences Holdings, Inc. trades on the Nasdaq under the ticker symbol SNTI.
What industry is Senti Biosciences Holdings, Inc. in?
Senti Biosciences Holdings, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Senti Biosciences Holdings, Inc. headquartered?
Senti Biosciences Holdings, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Senti Biosciences Holdings, Inc.'s fiscal year end?
Senti Biosciences Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Senti Biosciences Holdings, Inc. report?
Senti Biosciences Holdings, Inc. reported $22,000 in revenue for calendar year 2025, according to its SEC filings.